MYELODYSPLASTIC SYNDROME
Clinical trials for MYELODYSPLASTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy trial aims to boost red blood cells in blood cancer patients
Disease control Not yet recruitingThis study tests whether adding other drugs to luspatercept helps patients with a lower-risk type of myelodysplastic syndrome (MDS) who have anemia. The goal is to improve red blood cell counts and reduce the need for blood transfusions. About 270 adults who haven't had prior MDS…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Scientists harness donor exercise to supercharge Anti-Cancer cells
Disease control Not yet recruitingThis early-stage study is testing a new approach to prevent or treat leukemia relapse after a bone marrow transplant. Researchers collect immune cells from a related donor after the donor completes exercise sessions, hoping these 'exercise-mobilized' cells are better at finding a…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New 'Living Drug' trial targets tough blood cancers
Disease control Not yet recruitingThis is a first-in-human study testing a new type of CAR T-cell therapy for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or not responded to other treatments. Doctors will collect a patient's own immune cells, genetically…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE1 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug combo aims to knock out tough blood cancers
Disease control Not yet recruitingThis study is testing if adding a new drug called olutasidenib to standard treatments helps patients with certain blood cancers. It is for adults newly diagnosed with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS) who have a specific genetic change called an IDH1 …
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt for a new target to fight Pre-Leukemia
Knowledge-focused Not yet recruitingThis study aims to gather information to see if a protein on certain blood cancer cells, called IL-1RAP, could be a good target for a future CAR-T cell therapy. Researchers will collect blood and bone marrow samples from 120 patients with myelodysplastic syndromes (MDS), a type o…
Matched conditions: MYELODYSPLASTIC SYNDROME
Phase: NA • Sponsor: University Hospital, Grenoble • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:42 UTC
-
Scientists probe Body's natural cancer fighters in blood disease patients
Knowledge-focused Not yet recruitingThis study aims to learn more about how the body's natural killer (NK) immune cells fight blood cancers like leukemia. Researchers will collect blood and bone marrow samples from 55 adult patients with acute leukemia or myelodysplastic syndrome at diagnosis and over one year. The…
Matched conditions: MYELODYSPLASTIC SYNDROME
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC